Contraception
Volume 78, Issue 4, Supplement , Pages S28-S35 , October 2008

Bridging the gap between male and female fertility control; contraception-on-demand

Received 27 March 2008 ,Accepted 27 March 2008.

References 

  1. Asbell B. The Pill. New York: Random House; 1995;
  2. Ross JA, Winfrey WL. Unmet need for contraception in the developing world and the former Soviet Union: an updated estimate. Internat Fam Plann Perspec. 2002;28:138–143
  3. Ahman E, Shah IH. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000. 4th ed.. Geneva: World Health Organization; 2004;
  4. UNFPA . State of the world population in 2004: The Cairo concensus at ten: population, reproductive health and the global effort to end poverty. New York: UNFPA; 2003;
  5. World Health Organization . Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva: World Health Organization; 2001;
  6. UNAIDS and World Health Organization . AIDS epidemic update. Geneva: UNAIDS and World Health Organization; 2006;
  7. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis. 2005;16:235–244
  8. Macaluso M, Blackwell R, Jamieson DJ, et al. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol. 2007;166:88–96
  9. Kuyoh MA, Toroitich-Ruto C, Grimes DA, Schulz KF, Gallo MG. Sponge versus diaphragm for contraception. Cochrane Database Syst Rev. 2002;CD003172
  10. Miller CJ, Alexander NJ, Gettie A, Hendrickx AG, Marx PA. The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertil Steril. 1992;57:1126–1128
  11. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis. 2001;184:418–428
  12. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971–977
  13. Patton DL, Kidder GG, Sweeney YC, Rabe LK, Hillier SL. Effects of multiple applications of benzalkonium chloride and nonoxynol-9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol. 1999;180:1080–1087
  14. Belec L, Tevi-Benissan C, Bianchi A, et al. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J Antimicrob Chemother. 2000;46:685–693
  15. Vitali B, Pugliese C, Biagi E, et al. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol. 2007;73:5731–5741
  16. Zhou X, Brown CJ, Abdo Z, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 2007;1:121–133
  17. Setty BS, Kamboj VP, Garg HS, Khanna NM. Spermicidal potential of saponins isolated from Indian medicinal plants. Contraception. 1976;14:571–578
  18. Ojha P, Maikhuri JP, Gupta G. Effect of spermicides on Lactobacillus acidophilus in vitro — nonoxynol-9 vs. sapindus saponins. Contraception. 2003;68:135–138
  19. D'Cruz OJ, Uckun FM. Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des. 2004;10:315–336
  20. Roy S, Gourde P, Piret J, et al. Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrob Agents Chemother. 2001;45:1671–1681
  21. D'Cruz OJ, Uckun FM. Preclinical evaluation of a dual-acting microbicidal prodrug whi-07 in combination with vanadocene dithiocarbamate in the female reproductive tract of rabbit, pig, and cat. Toxicol Pathol. 2007;35:910–927
  22. Jain RK, Maikhuri JP, Kiran Kumar ST, et al. Novel disulphide esters of carbothioic acid as potent, non-detergent spermicides with low toxicity to Lactobacillus and HeLa cells in vitro. Hum Reprod. 2007;22:708–716
  23. Bourinbaiar AS, Coleman CF. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro. Arch Virol. 1997;142:2225–2235
  24. Bourinbaiar AS, Lee CH. Synergistic effect of gramicidin and EDTA in inhibiting sperm motility and cervical mucus penetration in vitro. Contraception. 1996;54:367–372
  25. Centola GM. Dose-response effects of gramicidin-D, EDTA, and nonoxynol-9 on sperm motion parameters and acrosome status. Contraception. 1998;58:35–38
  26. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, Shattock RJ. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol. 2000;74:5577–5586
  27. Hlivko JT, Chakraborty S, Hlivko TJ, Sengupta A, James PF. The human Na,K-ATPase alpha 4 isoform is a ouabain-sensitive alpha isoform that is expressed in sperm. Mol Reprod Dev. 2006;73:101–115
  28. Baker MA, Reeves G, Hetherington L, Müller J, Baur I, Aitken RJ. Identification of gene products present in Triton X-100 soluble and insoluble fractions of human spermatozoa lysates using LC-MS/MS analysis. Proteomics – Clin Appli. 2007;1:524–532
  29. Sanchez G, Nguyen AN, Timmerberg B, Tash JS, Blanco G. The Na,K-ATPase alpha 4 isoform from humans has distinct enzymatic properties and is important for sperm motility. Mol Hum Reprod. 2006;12:565–576
  30. Woo AL, James PF, Lingrel JB. Roles of the Na,K-ATPase alpha 4 isoform and the Na+/H+ exchanger in sperm motility. Mol Reprod Dev. 2002;62:348–356
  31. Wang D, Hu J, Bobulescu IA, et al. A sperm-specific Na+/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC). Proc Natl Acad Sci U S A. 2007;104:9325–9330
  32. Quill TA, Wang D, Garbers DL. Insights into sperm cell motility signaling through sNHE and the CatSpers. Mol Cell Endocrinol. 2006;250:84–92
  33. Aitken RJ, Harkiss D, Knox W, Paterson M, Irvine S. On the cellular mechanisms by which the bicarbonate ion mediates the extragenomic action of progesterone on human spermatozoa. Biol Reprod. 1998;58:186–196
  34. Olmsted SS, Dubin NH, Cone RA, Moench TR. The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril. 2000;73:687–693
  35. Short RV. New ways of preventing HIV infection: thinking simply, simply thinking. Philos Trans R Soc Lond B Biol Sci. 2006;361:811–820
  36. Imade G, Sagay AS, Onwuliri V, Egah DZ, Potts M, Short V. Use of lemon or lime juice douches in women in Jos, Nigeria. Sex Health. 2005;2:237–239
  37. Umpierre SA, Hill JA, Anderson DJ. Effect of “Coke” on sperm motility. N Engl J Med. 1985;313:1351
  38. Hong CY, Shieh CC, Wu P, Chiang BN. The spermicidal potency of Coca-Cola and Pepsi-Cola. Hum Toxicol. 1987;6:395–396
  39. Munire M, Shimizu Y, Sakata Y, Minaguchi R, Aso T. Impaired hyperactivation of human sperm in patients with infertility. J Med Dent Sci. 2004;51:99–104
  40. Sukcharoen N, Keith J, Irvine DS, Aitken RJ. Definition of the optimal criteria for identifying hyperactivated human spermatozoa at 25 Hz using in-vitro fertilization as a functional end-point. Hum Reprod. 1995;10:2928–2937
  41. Nolan MA, Babcock DF, Wennemuth G, Brown W, Burton KA. Sperm-specific protein kinase A catalytic subunit Calpha2 orchestrates cAMP signaling for male fertility. Proc Natl Acad Sci U S A. 2004;101:13483–13488
  42. White DR, Aitken RJ. Relationship between calcium, cyclic AMP, ATP, and intracellular pH and the capacity of hamster spermatozoa to express hyperactivated motility. Gamete Res. 1989;22:163–177
  43. Jaiswal BS, Conti M. Calcium regulation of the soluble adenylyl cyclase expressed in mammalian spermatozoa. Proc Natl Acad Sci U S A. 2003;100:10676–10681
  44. Hess KC, Jones BH, Marquez B, et al. The “soluble” adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. Dev Cell. 2005;9:249–259
  45. Baker MA, Hetherington L, Aitken RJ. Identification of SRC as a key PKA-stimulated tyrosine kinase involved in the capacitation-associated hyperactivation of murine spermatozoa. J Cell Sci. 2006;119:3182–3192
  46. Quill TA, Ren D, Clapham DE, Garbers DL. A voltage-gated ion channel expressed specifically in spermatozoa. Proc Natl Acad Sci U S A. 2001;98:12527–12531
  47. Qi H, Moran MM, Navarro B, et al. All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility. Proc Natl Acad Sci U S A. 2007;104:1219–1223
  48. Mann T, Lutwak Mann C. Male reproductive function and semen. Berlin: Springer Verlag; 1981;
  49. Deana R, Ruzzene M, Cavallini L, Francesconi M, Rigoni F. Effects of calcium chelators, divalent cations and sulfhydryl reagents on calcium uptake and motility of bovine spermatozoa. Cell Calcium. 1988;9:121–128
  50. Dwivedi AK, Sharma VL, Kumaria N, et al. Synthesis of disulfide esters of dialkylaminocarbothioic acid as potent, non-detergent spermicidal agents. Bioorg Med Chem. 2007;15:6642–6648
  51. Davis CH, Raulston JE, Wyrick PB. Protein disulfide isomerase, a component of the estrogen receptor complex, is associated with Chlamydia trachomatis serovar E attached to human endometrial epithelial cells. Infect Immun. 2002;70:3413–3418
  52. Raulston JE, Davis CH, Paul TR, Hobbs JD, Wyrick PB. Surface accessibility of the 70-kilodalton Chlamydia trachomatis heat shock protein following reduction of outer membrane protein disulfide bonds. Infect Immun. 2002;70:535–543
  53. Matthias LJ, Yam PT, Jiang XM, et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol. 2002;3:727–732
  54. Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci U S A. 1994;91:4559–4563
  55. Anderson RA, Feathergill K, Kirkpatrick R, et al. Characterization of cysteamine as a potential contraceptive anti-HIV agent. J Androl. 1998;19:37–49
  56. Aitken RJ, Baker MA. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol. 2006;250:66–69
  57. Aitken RJ, De Iuliis GN. Origins and consequences of DNA damage in male germ cells. Reprod Biomed Online. 2007;14:727–733
  58. Jones AR, Cooper TG. A re-appraisal of the post-testicular action and toxicity of chlorinated antifertility compounds. Int J Androl. 1999;22:130–138
  59. Jelks KB, Miller MG. alpha-Chlorohydrin inhibits glyceraldehyde-3-phosphate dehydrogenase in multiple organs as well as in sperm. Toxicol Sci. 2001;62:115–123
  60. Cooper TG, Yeung CH. Recent biochemical approaches to post-testicular, epididymal contraception. Hum Reprod Update. 1999;5:141–152
  61. Bone W, Jones AR, Morin C, Nieschlag E, Cooper TG. Susceptibility of glycolytic enzyme activity and motility of spermatozoa from rat, mouse, and human to inhibition by proven and putative chlorinated antifertility compounds in vitro. J Androl. 2001;22:464–470
  62. Aitken RJ, Liu J, Best FS, Richardson DW. An analysis of the direct effects of gossypol on human spermatozoa. Int J Androl. 1983;6:157–167
  63. Aitken RJ. New techniques in contraception: gossypol, vaccines and GnRH analogues. Proc Annu Symp Eugen Soc. 1983;19:1–18
  64. Michael AE. 11-beta HSD and the mechanism of gossypol-induced hypokalemia. Int J Androl. 1998;21:313
  65. Yu YW. Probing into the mechanism of action, metabolism and toxicity of gossypol by studying its (+)- and (−)-stereoisomers. J Ethnopharmacol. 1987;20:65–78
  66. Lin TS, Schinazi R, Griffith BP, et al. Selective inhibition of human immunodeficiency virus type 1 replication by the (−) but not the (+) enantiomer of gossypol. Antimicrob Agents Chemother. 1989;33:2149–2151
  67. Hughes LM, Griffith R, Aitken RJ. The search for a topical dual action spermicide/microbicide. Curr Med Chem. 2007;14:775–786
  68. Veazey RS, Shattock RJ, Pope M, et al. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med. 2003;9:343–346
  69. Cheshenko N, Keller MJ, MasCasullo V, et al. Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread. Antimicrob Agents Chemother. 2004;48:2025–2036
  70. Patel S, Hazrati E, Cheshenko N, et al. Seminal plasma reduces the effectiveness of topical polyanionic microbicides. J Infect Dis. 2007;196:1394–1402
  71. Bourne N, Zaneveld LJ, Ward JA, Ireland JP, Stanberry LR. Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. Clin Microbiol Infect. 2003;9:816–822
  72. Lee CC, MacKay JA, Frechet JM, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol. 2005;23:517–526
  73. Graham DR, Chertova E, Hilburn JM, Arthur LO, Hildreth JE. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol. 2003;77:8237–8248
  74. Palliser D, Chowdhury D, Wang QY, et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature. 2006;439:89–94
  75. Vermeire K, Schols D. Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs. J Antimicrob Chemother. 2005;56:270–272
  76. Zairi A, Belaid A, Gahbiche A, Hani K. Spermicidal activity of dermaseptins. Contraception. 2005;72:447–453

 Author Disclosures: R. John Aitken, Louise M. Hughes, Renate Griffith, and Mark A. Baker do not report any conflicts of interest with the sponsor of this supplement article or products discussed in this article.

PII: S0010-7824(08)00282-5

doi: 10.1016/j.contraception.2008.03.020

Contraception
Volume 78, Issue 4, Supplement , Pages S28-S35 , October 2008